A quick note from our CEO Jeremy Skillington as @EBDgroup's BIO-Europe Spring 2026 comes to and end. The Poolbeg team were delighted to have attended the event, to discuss POLB 001, the TOPICAL trial and our oral GLP-1 programme. Poolbeg Pharma is heading to @LSXLeaders next! #POLB #BIOEuropeSpring #BIOEUROPE #Lisbon #Conference #Partnering

Delighted that #AVCT was part of the discussion of the emerging therapies in oncology, the reasons for hope and a panel that was truly focused on the future of oncology. So energizing to be in Lisboa this week. BIO has a real buzz! #BIOEuropeSpring #HopeWithoutCompromise

Avacta CEO Chris Coughlin joined an expert panel this week in Lisbon at #BIOEuropeSpring to discuss the latest innovation and opportunity shaping the oncology landscape, from precision medicine and immunotherapies to novel modalities and combination treatments. #AVCT

Hello from Lisbon! ☀️ Our team: Marcin Szumowski (CEO), Zbigniew Zaslona (CSO) and Maurycy Zieliński (Business Development Director), is currently attending #BIOEurope Spring 2026 in Portugal 🇵🇹 Great conversations and meaningful connections at #BIOEuropeSpring!

Just had a great chat with Antonio, the CEO of BIAL, the largest biopharma in Portugal 🇵🇹 Episode drops next week. #BIOEuropeSpring ☀️

🇵🇹 We’re delighted to be at BIO-Europe Spring in beautiful Lisbon, Portugal, alongside our colleagues from Prague.bio Come and meet us at BOOTH 73. 🤝🧬 For the next few days, this city is bringing together over 3,700 professional visitors and more than 2,000 exhibitors — and we’re very glad to be part of it. #BIOEuropeSpring #Lisbon #Biotech #LifeSciences #Networking #Innovation

#BioEuropeSpring: Looking for ‘tip of the spear science’ via M&As, investments bioworld.com/articles/729814 #biopharma #deals #investment

BIO is on the ground at #BIOEuropeSpring! With 18,000 one-to-one meetings and nearly 2,000 companies convening, this week is about the partnerships that will strengthen our innovation ecosystem. The BIO team is there to support partnering across every stage of development - and connect attendees to BIO’s investment and collaboration platforms, including Investor Connect Plus, a @LaunchBio x BIO partnership. If you're attending, come find us at Booth 103!

#AseBioDíaADía | Asistimos en Lisboa a la nueva edición de #BIOEuropeSpring, una de las grandes citas del sector a nivel europeo. #SomosBiotecnología

🇵🇹☀️ First recording at BIO-Europe Spring with one of the best biotech investors in Europe: Sander Slootweg, the cofounder of Forbion. Episode drops mid-April. #BIOEuropeSpring

As we open in Lisbon at #BIOEuropeSpring a short reflection on the two groups of people who make our industry work - the patients who sign on to trials and #ThePeopleBehindthePurpleMedicine #BringYourAGame #AVCT linkedin.com/pulse/who-behin… via @LinkedIn

@TonixPharma is heading to Lisbon for #BIOEuropeSpring 2026. Our CEO, Seth Lederman, MD, will deliver a company presentation highlighting our progress on Tuesday, March 24. Read more: bit.ly/4uzAHHy #TonixPharmaceuticals #BIOEuropeSpring #Biotech #LifeSciences

Medincell will be at #BIOEuropeSpring! James Gubbins, PhD, will be in Lisbon (Mar 23–25) to explore partnerships and present our BEPO® LAI technology. 🤝Want to meet? Contact James via the partnering platform. #BIO #BIOEurope #Biotech #Pharma #Partnering #BIOEuropeSpring2026

Our Business Development team is heading to Lisbon later this month for #BIOEuropeSpring and @LSXLeaders. As we continue to advance our pipeline of next-generation #ADCs, we look forward to meeting with potential partners and investors. Please reach out to Martin Vodak or Norbert Prenzel if you’re attending and would like to meet. @EBDGroup #BIOEurope #BiotechPartnering #OncologyInnovation #CancerTherapy #LSX

We will be attending #BIOEuropeSpring & #DCATWeek! Let’s connect & discuss how our full-service global CRO capabilities can support your clinical development goals. To schedule a meeting📧BD@lambda-cro.com #LambdaTherapeuticResearch #LambdaCRO #LambdaNovum #DCAT #BIOEurope

📅 [#Event] – Meet Frederic Fasano, Chief Strategy and Corporate Development Officer at MaaT Pharma, and Guilhaume Debroas, Head of Corporate Development, at #BIOEurope Spring on March 23-25, 2026, in Lisbon, Portugal. As one of Europe’s leading partnering events in life sciences, BIO-Europe Spring brings together biotech innovators, pharma leaders and investors to shape the future of healthcare. We look forward to connecting with potential partners to discuss collaboration opportunities in microbiome-based therapies, with a focus on oncology and innovative development strategies. 👉 More information here: informaconnect.com/bioeurope… @EBDgroup #Pharma #Innovation #Biotech #Microbiome #Lifesciences #Oncology #BIOEuropeSpring

Meet our CEO & CFO at the @EBDgroup's BIO-Europe Spring. 📍Lisbon, Portugal 🗓️ 23-25 March 2026 🤝Connect & schedule a meeting via PartneringOne The team looks forward to connecting with industry leaders, partners, and innovators from across the global life sciences community. #BIOEuropeSpring #Biopharma #LifeSciences #Partnering #Innovation #ClinicalResearch

1 month to #BIOEuropeSpring ⏳ Ready to connect and talk biologics development & GMP manufacturing.

🤝 We will be at #BIOEuropeSpring Francisco and Javier are attending, ready to connect and talk biologics manufacturing and collaboration.

#BioEuropeSpring in Milan! ✨ It was our very first time speaking as Symbiotica Therapeutics! We pitched how a single local therapeutic tattoo can change the future of chronic disease treatment. Huge thanks to everyone who showed up, asked questions, and shared ideas! #Biotech